Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
KASTx Ventures Inc. is a Calgary-based venture capital firm that specializes in biotechnology and life sciences startups. Founded with the mission to support world-leading biotech companies, KASTx Ventures provides essential resources to transform disruptive ideas into viable businesses. The firm is particularly focused on ventures that enhance societal outcomes in health and technology, with a strong emphasis on therapeutic development, medical devices, and digital health technologies.
Currently, KASTx Ventures manages a fund size of CA$5 million, targeting pre-seed and seed stage investments. The firm has a portfolio of six companies, reflecting its commitment to fostering innovation in the life sciences sector. KASTx Ventures is dedicated to commercializing life-sciences research and supporting early-stage companies that create a positive societal impact.
KASTx Ventures primarily invests in pre-seed and seed stage companies within the life sciences sector, specifically targeting startups that are developing innovative solutions in therapeutic development, medical devices, and digital health. The firm seeks projects that demonstrate strong technical validation and a credible commercialization roadmap. KASTx Ventures emphasizes the importance of quality data, milestone achievement, and a solid regulatory path in its investment evaluations.
The firm operates primarily in North America, with a focus on the United States and Canada. KASTx Ventures aims to support companies that not only advance health technology but also contribute to environmental sustainability. This dual focus on health and sustainability positions KASTx Ventures as a key player in the biotechnology investment landscape.
KASTx Ventures has invested in a diverse range of companies within the life sciences sector. Notable portfolio companies include:
This portfolio reflects KASTx Ventures' commitment to supporting innovative solutions that address critical challenges in health and technology.
Lawrence Korngut - Founder of KASTx Ventures, with a background in biotechnology investments and a focus on supporting early-stage companies.
Christian Idicula - COO, previously held roles at UBS, Deloitte, and PwC, bringing extensive operational experience to KASTx Ventures.
Janet Petrillo Ballantyne - Employee at KASTx Ventures, with a role that is not publicly disclosed.
Sanjana Mittal - Employee at KASTx Ventures, with a role that is not publicly disclosed.
In June 2023, KASTx Ventures announced the first close of its KASTx Life Science Fund I, targeting CA$5 million to invest in pre-seed and seed stage life sciences companies. This fund aims to support innovative ventures in therapeutic development, medical devices, and digital health technologies.
Despite the positive fund activity, KASTx Ventures' online presence is currently limited, with their official website not operational. Founders are advised to verify the firm's current status before pursuing engagement.
What are KASTx Ventures' investment criteria?
KASTx Ventures focuses on pre-seed and seed stage companies in the life sciences sector. They look for startups that demonstrate strong technical validation and a credible commercialization roadmap, particularly in therapeutic development, medical devices, and digital health.
How can founders pitch to KASTx Ventures?
Specific details regarding the pitch process are not disclosed. Founders are encouraged to reach out through professional networks or LinkedIn to establish connections.
What makes KASTx Ventures different from other investors?
KASTx Ventures emphasizes the importance of societal impact in health and technology. They provide not only capital but also access to industry expertise and resources that are crucial for early-stage life sciences ventures.
What is the geographic focus of KASTx Ventures?
The firm primarily invests in North America, specifically targeting startups in the United States and Canada.
What is the fund size of KASTx Ventures?
KASTx Ventures has a fund size of CA$5 million, which is aimed at supporting early-stage life sciences companies.
What kind of support do portfolio companies receive?
KASTx Ventures provides access to industry expertise, resources, and networks that are essential for the growth of early-stage life sciences ventures. They emphasize milestone achievement and a solid regulatory path in their support.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.